ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
US Tech 100
19,408.40
0.00%
Dow Jones
38,834.86
0.15%
Brent Oil
84.645
-0.06%
Bitcoin
65,556.81
0.91%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. CytoMed Therapeutics Ltd (GDTC) Quote

CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd (GDTC)

NASDAQ
1.93
0.00
(0.00%)
Closed June 20 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.93
Bid
0.792
Ask
2.25
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
22.252M
Previous Close
1.93
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
11,529,330
Dividend Yield
-
PE Ratio
-5.38
Earnings Per Share (EPS)
-0.36
Revenue
518k
Net Profit
-4.13M

About CytoMed Therapeutics Ltd

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cytomed.sg.
Headquarters
Singapore, Sgp
Founded
1970
CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was $1.93. Over the last year, CytoMed Therapeutics shares have traded in a share price range of $ 0.00 to $ 0.00.

CytoMed Therapeutics currently has 11,529,330 shares outstanding. The market capitalization of CytoMed Therapeutics is $22.25 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -5.38.

GDTC Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 24 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

May 23 2024
Edgar (US Regulatory)

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

March 18 2024
GlobeNewswire Inc.

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

March 04 2024
GlobeNewswire Inc.

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

January 29 2024
GlobeNewswire Inc.

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology PR Newswire SINGAPORE, Dec. 5, 2023 SINGAPORE, Dec. 5, 2023 /PRNewswire/ -- CytoMed...

December 05 2023
PR Newswire (US)

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update PR Newswire SINGAPORE, Nov. 17, 2023 Conference call webcast is scheduled for November 22 at 9 a.m...

November 17 2023
PR Newswire (US)

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference PR Newswire SINGAPORE, Nov. 14, 2023 SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- CytoMed...

November 14 2023
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.359
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.855
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.61
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.48
(0.00%)
0
AACGATA Creativity Global
$ 0.8409
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.359
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.855
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.61
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.48
(0.00%)
0
AACGATA Creativity Global
$ 0.8409
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.359
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.855
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.61
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.48
(0.00%)
0
AACGATA Creativity Global
$ 0.8409
(0.00%)
0

GDTC Discussion

View Posts
Monksdream Monksdream 2 months ago
GDTC under $3
👍️0
Awl416 Awl416 4 months ago
Halt
👍️0
Monksdream Monksdream 11 months ago
GDTC gap fill candidate bears gotta love it
👍️0
Eurotradr Eurotradr 11 months ago
So much further to go. $10 min.
👍️0
Monksdream Monksdream 11 months ago
GDTC No 1 on the early Barchart Top 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
AJ Freely AJ Freely 11 months ago
$GDTC -Up 300% from yesterdays close
A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US
Current Price $9.63
👍️0
Monksdream Monksdream 11 months ago
Nurse Sherry bought 100 at $7.50
👍️0

Your Recent History

NASDAQ
GDTC
CytoMed Therapeutics
LSE
BM48
Pref Res 3 A 33
TG
DU8S
Genetic Technologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved